Laboratory Control of Continuous Intravenous Heparin Therapy with Howel Time and Activated Partial Thromboplastin Time A Prospective, Randomized and Blind Study

Almazan, Arturo; Lozano, Francisco; Ramos, Manuel; Rodriguez-Moran, Manuel; Gomez-Alonso, Alberto
June 1985
Angiology;Jun1985, Vol. 36 Issue 6, p363
Academic Journal
Although heparin has been used extensively to treat Deep Venous Thrombosis (DVT) and arterial ischemia (AI), controversy still exists regarding optimal dosage and the need for monitoring. Different authors have employed various test with variable results. Others, however, persist in giving heparin without laboratory control. This study was made in order to compare, in a prospective, randomized and blind manner, two coagulation tests, namely: Howel Time (HT) and Activated Partial Thromboplastin Time (APTT), in controlling the dose of heparin given by continuous intravenous infusion in DVT and At. Our results show no significant difference in complications and failures of the therapy with either test, although significantly higher doses of heparin were needed to maintain APTT within therapeutic range than those needed to keep HT within a similar range.


Related Articles

  • Differential Effects of Unfractionated Heparin and Low-Molecular-Weight Heparins on Tissue Thromboplastin Inhibition Test. Gerbutavicius, Rolandas; Iqbal, Omer; Messmore, Harry; Hoppensteadt, Debra A.; Demir, Muzaffer; Khan, Erum; Bacher, Peter; Fareed, Jawed // Clinical & Applied Thrombosis/Hemostasis;Oct2000, Vol. 6 Issue 4, p190 

    Circulating anticoagulants are endogenously produced substances that interfere with in vitro tests of coagulation like activated partial thromboplastin time (APTT). and cause prolongation of the clotting times. Evaluation of the abnormal APTT involving various factor assays and mixing studies...

  • Evaluation of Heparin Assay for Coagulation Management in Newborns Undergoing ECMO. Khaja, Wassia A.; Bilen, Ozlem; Lukner, Ralf B.; Edwards, Rachel; Teruya, Jun // American Journal of Clinical Pathology;Dec2010, Vol. 134 Issue 6, p950 

    The objective was to identify the usefulness of heparin level by anti--factor Xa (anti-Xa) assay vs activated partial thromboplastin time (PTT) or activated clotting time (ACT) in neonates undergoing extracorporeal membrane oxygenation (ECMO). A retrospective record review of 21 patients in the...

  • Sequential thrombosis and bleeding in a woman with a prolonged activated partial thromboplastin time.  // Thrombosis Journal;2011, Vol. 9 Issue 1, p16 

    The article presents a case study of sequential occurrence of thrombosis and haemorrhage in a 37-year-old woman. The woman was presented to casualty for pain and swelling in the right calf; and a Doppler ultrasound revealed a clot in the right femoral vein and in the deep veins of the right...

  • Heparins: Clinical Use and Laboratory Monitoring. Hoffman, Maureane // Laboratory Medicine;Oct2010, Vol. 41 Issue 10, p621 

    Heparin has long been used as an anti-thrombotic to treat and prevent thromboembolic events, as well as for systemic anti-coagulation during cardiopulmonary bypass and dialysis. Heparin continues to have distinct advantages when intense anti-coagulation is needed, but newer low molecular weight...

  • aPTT in Heparinized Patients: Influence of the Interval Between Sampling and Testing. Rachakonda, Vikrant; Rachakonda, Leelanand; Belliveau, Robert R. // Clinical & Applied Thrombosis/Hemostasis;Jul1998, Vol. 4 Issue 3, p213 

    Activated partial thromboplastin times(aPTTs) from, 29 whole blood samples were drawn from patients receiving unfractionated heparin through a constant intravenous drip. Three aPTTs were determined for each whole blood sample. The first aPTT was performed on a separate portion of the original...

  • Towards a standardization of thrombin generation assessment: The influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay. Gerotziafas, Grigoris T.; Depasse, François; Busson, Joël; Leflem, Lena; Elalamy, Ismail; Samama, Meyer M. // Thrombosis Journal;2005, Vol. 3, p16 

    Background: Thrombin generation assay was developed several years ago to mimic physiological coagulation mechanisms but it had important limitations. Thrombogram-Thrombinoscope assay using a fluorogenic substrate, allows obtaining thrombin generation curves in non-defibrinated platelet rich...

  • ASHP Therapeutic Position Statement on the Use of Low-Molecular-Weight Heparins for Adult Outpatient Treatment of Acute Deep-Vein Thrombosis.  // American Journal of Health-System Pharmacy;9/15/2004, Vol. 61 Issue 18, p1950 

    Presents the position of the American Society of Health-System Pharmacists (ASHP) with regards to the use of low-molecular-weight heparins for adult outpatient treatment of acute deep-vein thrombosis (DVT). Evidence of efficacy and safety; Cost-effectiveness; Patient satisfaction; Successful...

  • DEEP VEIN THROMBOSIS TREATED WITH STREPTOKINASE OR HEPARIN. Seaman, Arthur J.; Common, Herbert H.; Rösch, Josef; Dotter, Charles T.; Porter, John M.; Lindell, Thomas D.; Lawler, William L.; Schlueter, William J. // Angiology;Oct1976, Vol. 27 Issue 10, p549 

    Randomly assigned streptokinase or heparin therapy was studied in 50 patients with deep vein thrombosis of less than 2 weeks' duration. Venography was performed prior to therapy, after 3 days, and after 10 days. Two radiologists who were unaware of the patient's therapy compiled a single average...

  • Activated Partial Thromboplastin Time and Anti-Xa Measurements in Heparin Monitoring. Takemoto, Clifford M.; Streiff, Michael B.; Shermock, Kenneth M.; Kraus, Peggy S.; Chen, Junnan; Jani, Jayesh; Kickler, Thomas // American Journal of Clinical Pathology;Apr2013, Vol. 139 Issue 4, p450 

    We examined the concordance of heparin levels measured by a chromogenic anti-Xa assay and the activated partial thromboplastin time (APTT) during unfractionated heparin therapy (UFH) and the biochemical basis for differences between these measures. We also investigated the endogenous thrombin...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics